RARECYTE INC.

In News

RareCyte Expands Clinical-Scale Spatial Proteomics Portfolio with New Orion Systems and Leadership Appointment - BioSpace

BioSpace - Apr 20, 2026

RareCyte® announces research grant to investigate molecular profile of circulating trophoblasts in fetal growth restriction - Drug Discovery News

Drug Discovery News - Aug 26, 2025

RareCyte secures $20M financing to expand the Orion™ Spatial Biology platform including Multiplex Assay Reagents, Software and Precision Biology Services - PR Newswire

PR Newswire - Jun 27, 2024

New test might expand ability to find tumor cells in blood - UW Medicine | Newsroom

UW Medicine | Newsroom - Jun 21, 2023

High-plex immunofluorescence imaging and traditional histology of the same tissue section for discovering image-based biomarkers - Nature

Nature - Jun 22, 2023

Immunofluorescent and molecular characterization of effusion tumor cells reveal cancer site-of-origin and disease-driving mutations - Wiley & Sons

Wiley & Sons - Jun 22, 2022

Liquid biopsy startup RareCyte announces $30M round and new CEO to fuel rare cell detection - GeekWire

GeekWire - Aug 29, 2017

Advanced spatial biology for faster therapeutic research - SelectScience interview - SelectScience

SelectScience - Feb 10, 2025

Exploring new frontiers in pancreatic cancer treatment with spatial biology - Drug Discovery News

Drug Discovery News - Mar 26, 2025

Identification and characterization of effusion tumor cells (ETCs) from remnant pleural effusion specimens - Wiley & Sons

Wiley & Sons - Jun 25, 2021

Stay Informed

Join our mailing list for the latest report releases and upcoming event notifications.

Headquartered in Boston, Mass., for over 50 years, BCC Research takes pride in being your trusted custom research and data analysts. Our mission is to provide businesses with reputable data and market research reports, so that they gain new perspectives into their field and better understand their target audience. We enable companies to access reliable information, accurate forecasts, and actionable insights, so that they may become leaders in their industry.

AI Sentiment